// App-Quantinova.ai

158 : New Therapeutic Approach for the Treatment of B-Cell Disorders Using Chlorambucil/Hydroxychloroquine-Loaded AntiCD20 Nanoparticles

Researchers

Presenter

  • Nelly Mezzaroba

Principal Investigators

  • Sonia Zorzet

  • Chiara Garrovo

  • Gustavo Marin

  • Edoardo Mansilla

  • Paolo Macor

  • Erika Secco

  • Stefania Biffi

  • Claudio Tripodo

  • Marco Calvaruso

  • Luis Nunez

  • Rubens Spretz

  • Gustavo Larsen

  • Sandra Noriega

Medical Centers

  • LNK Chemosolutions, Lincoln, NV, USA,

  • Dept. of Hematology, University of Palermo, Palermo, Italy

  • Department of Medical Surgical and Health Sciences U.C.O. Medicina Clinica, University of Trieste, Trieste, Italy

  • Optical Imaging Laboratory, Area Science Park, Trieste, Italy

  • Department of Health Sciences, Human Pathology Section, University of Palermo, Palermo, Italy

  • CUCAIBA, Ministry of Health, Buenos Aires, Argentina

  • LNK Chemosolutions, Lincoln, NV, USA,

  • Dept. of Life Sciences, University of Trieste, Trieste, Italy

  • Dept. of Life Sciences, University of Trieste, Trieste, Italy

Locations

  • United States

  • Argentina

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Lympho proliferative disease

  • Chronic Lymphocytic Leukemia

  • Burkitt lymphoma

  • Lymphomas

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Hydroxychloroquine

  • chlorambucil

  • Rituximab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved